Freeline is an England-based biotechnology company that develops and commercializes AAV-focused gene therapies for the treatment of hemophilia and LSDs.
Business Model:
Revenue: $0
Employees: 201-500
Address: Gunnels Wood Road
City: Stevenage
State: england
Zip: SG1 2FX
Country: GB
Freeline is an England-based biotechnology company that develops and commercializes AAV-focused gene therapies for the treatment of hemophilia and LSDs.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
Ticker Symbol:
FRLN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2022 | Post-IPO Equity | $26.1M | 6/2019 | Series B | $112.4M |
Syncona Ltd University College London |
12/2019 | Series C | $40M |
Syncona |
8/2020 | IPO | $158.8M |
|
6/2020 | Series C | $80M |
Novo Holdings A/S Eventide Asset Management Wellington Management Company Cowen Healthcare Investments Acorn Bioventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|